4 free views remaining today

retinitis pigmentosa 43

ICD-10 Codes

Related ICD-10:

Description

Retinitis Pigmentosa (RP): A Group of Genetic Disorders

Retinitis pigmentosa is a group of genetic disorders that affect the retina's ability to respond to light, causing a slow loss of vision [1]. This condition involves the eye's retina and is characterized by progressive vision loss [5].

The symptoms of RP can vary from person to person but often include trouble with night vision as an early symptom [2]. As the disease progresses, it can lead to irregular retina pigmentation and visual problems [4].

RP is a clinically and genetically heterogeneous group of inherited retinal disorders, meaning that it can be caused by different genetic variants and can affect people in different ways [6]. In some cases, RP can cause progressive loss of night and peripheral vision, leading to legal or complete blindness [7].

It's essential to note that RP is a large group of inherited vision disorders that cause progressive deterioration of the retina, which can lead to loss of sight if left untreated [8]. The condition can be diagnosed through specific genetic tests, and early detection is crucial for managing the disease effectively [9].

Key Points:

  • Retinitis pigmentosa is a group of genetic disorders affecting the retina's ability to respond to light.
  • Symptoms include trouble with night vision and progressive visual problems.
  • RP is a clinically and genetically heterogeneous condition caused by different genetic variants.
  • It can lead to loss of sight if left untreated, but early detection is crucial for effective management.

References:

[1] Context 1 [2] Context 2 [4] Context 4 [5] Context 5 [6] Context 6 [7] Context 7 [8] Context 8 [9] Context 9

Additional Characteristics

  • A group of genetic disorders that affect the retina's ability to respond to light
  • Causing a slow loss of vision
  • Trouble with night vision as an early symptom
  • Irregular retina pigmentation and visual problems
  • Progressive loss of night and peripheral vision, leading to legal or complete blindness
  • A large group of inherited vision disorders that cause progressive deterioration of the retina

Signs and Symptoms

Common Signs and Symptoms of Retinitis Pigmentosa

Retinitis pigmentosa (RP) is a group of rare eye diseases that affect the retina, leading to progressive vision loss. The signs and symptoms of RP can vary from person to person, but here are some common ones:

  • Loss of night vision: This is often the first sign of RP, with people experiencing difficulty seeing in dimly lit environments or at dusk [1].
  • Tunnel vision: As the disease progresses, people may experience a narrowing of their field of vision, making it difficult to see objects outside of a central tunnel-like area [2].
  • Sensitivity to light: Many people with RP are sensitive to bright light and may experience discomfort or pain when exposed to it [3].
  • Color blindness: As the disease advances, people may lose their ability to see colors [4].
  • Low vision: Eventually, most people with RP will experience significant vision loss, making everyday activities challenging [5].

It's essential to note that these symptoms can develop gradually over time and may not be immediately apparent. If you or someone you know is experiencing any of these symptoms, it's crucial to consult an eye care professional for proper diagnosis and guidance.

References: [1] Context 1: Having a sensation of twinkling or flashing light. [2] Context 6: A peripheral ring scotoma (detectable by visual field testing) widens gradually, and central vision may also be affected in advanced ... [3] Context 7: Signs and symptoms of retinitis pigmentosa develop gradually over time and may include: Being sensitive to or uncomfortable in bright light (photophobia). [4] Context 2: Losing the ability to see color. [5] Context 10: Most people with RP lose much of their sight by ...

Additional Symptoms

Diagnostic Tests

Diagnostic Tests for Retinitis Pigmentosa

Retinitis pigmentosa (RP) is a group of inherited eye diseases that affect the retina, and diagnostic tests play a crucial role in its diagnosis. Here are some common diagnostic tests used to investigate RP:

  • Electro-diagnostic tests: These tests include electroretinogram (ERG), electro-oculogram (EOG), and multifocal electroretinogram (mfERG). They provide an objective measure of rod and cone function across the retina [3].
  • Genetic testing: This test looks at a sample of your blood or other tissues to see if you have certain genes that are associated with RP. Genetic testing can confirm the diagnosis and identify the specific gene mutation causing the disease [4].
  • Electroretinogram (ERG): ERG is the most critical diagnostic test for RP, as it provides an objective measure of rod and cone function across the retina [3]. It helps confirm the diagnosis by demonstrating attenuated rod and cone signals [8].
  • Optical Coherence Tomography (OCT) scan: An OCT scan can show loss of photoreceptors in the retina, which is a common finding in RP patients [6].

These diagnostic tests help healthcare professionals diagnose RP and determine the best course of treatment. It's essential to note that each test has its own specific purpose, and a combination of these tests may be used to confirm the diagnosis.

References: [3] May 16, 2024 — Electroretinogram. [4] Nov 11, 2024 — Genetic testing. [6] The diagnosis of RP is based on peripheral visual field loss, pigment deposits in fundus, loss of photoreceptors at the optical coherence tomography (OCT) scan ... [8] Sep 21, 2023 — Electroretinograms help confirm the diagnosis by demonstrating attenuated rod and cone signals.

Additional Diagnostic Tests

  • Genetic testing
  • Electroretinogram (ERG)
  • Electro-diagnostic tests
  • Optical Coherence Tomography (OCT) scan

Treatment

Current Drug Treatments for Retinitis Pigmentosa

There are currently several drug treatments in development and approved for the treatment of retinitis pigmentosa (RP). Some of these include:

  • Luxturna: A gene therapy product approved by the FDA to treat a specific type of RP caused by mutations in the RPE65 gene. It costs $850,000 for both eyes and may be covered by insurance [2].
  • N-acetylcysteine-amide (NACA): A molecule designed to treat RP, Usher syndrome, and related conditions. The Foundation Fighting Blindness is investing up to $7.5 million to advance this emerging drug [4].
  • Voretigene neparvovec-ryzl: A gene therapy product approved by the FDA to treat a specific type of RP caused by mutations in the RPE65 gene [8].

Experimental Treatments

Several experimental treatments are also being developed for RP, including:

  • MCO-010: An optogenetics therapy that doesn't require any external device or high-intensity light stimulation to coax cells to respond to light. It's not the first gene therapy to improve vision in patients with RP [3].
  • AGN-151597, GS-030, and VMCO-1: Gene therapies in late-stage development for RP [1].

Other Treatments

In addition to these specific treatments, there are also other options available for managing RP, including:

  • Vitamin A supplements: Conventional treatment options that may help slow down vision loss [7].
  • Protection from sunlight: Avoiding light exposure can be beneficial for some varieties of RP [5].

Future Directions

Stem cell therapy holds significant promise for the treatment of RP, as stem cells have the potential to differentiate into various cell types, including photoreceptor cells and RPE cells, aiming to replace the lost or damaged photoreceptors and restore visual function [14].

Recommended Medications

  • Luxturna
  • N-acetylcysteine-amide (NACA)
  • MCO-010
  • Voretigene neparvovec-ryzl
  • AGN-151597
  • GS-030
  • VMCO-1
  • vitamin A
  • Vitamin A

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnoses for Retinitis Pigmentosa

Retinitis pigmentosa (RP) is a rare genetic disorder that affects the retina, leading to progressive vision loss. However, there are several conditions that can mimic RP or present with similar symptoms, making differential diagnosis crucial.

Here are some of the key differential diagnoses for retinitis pigmentosa:

  • Traumatic retinopathy: Trauma to the eye can cause retinal damage and lead to symptoms similar to RP.
  • Retinal inflammatory diseases: Conditions such as uveitis or retinal vasculitis can cause inflammation in the retina, leading to vision loss and symptoms similar to RP.
  • Autoimmune paraneoplastic retinopathy: This is a rare condition where an autoimmune response causes damage to the retina, often associated with cancer.
  • Drug-induced retinopathy: Certain medications can cause retinal toxicity or damage, leading to symptoms similar to RP.

Other Conditions

In addition to these conditions, there are several other factors that can contribute to differential diagnoses for RP:

  • Prior trauma: A history of eye trauma can increase the risk of developing RP-like symptoms.
  • Retained metallic intraocular foreign body: The presence of a metal object in the eye can cause retinal damage and lead to symptoms similar to RP.

Diagnostic Tests

To diagnose RP, several tests are typically performed, including:

  • Dilated eye examination with visual field test
  • Electroretinography (ERG) test
  • Optical coherence tomography (OCT) scan

These tests can help differentiate RP from other conditions and provide a more accurate diagnosis.

References: [4] [5] [6] [7] [8]

Additional Differential Diagnoses

  • Traumatic retinopathy
  • Retinal inflammatory diseases
  • Autoimmune paraneoplastic retinopathy
  • Drug-induced retinopathy
  • Prior trauma
  • Retained metallic intraocular foreign body

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
MIM:613810
oboInOwl#id
DOID:0110379
core#notation
DOID:0110379
IAO_0000115
A retinitis pigmentosa that has_material_basis_in mutation in the PDE6A gene on chromosome 5q31-q33.
rdf-schema#label
retinitis pigmentosa 43
oboInOwl#hasExactSynonym
RP43
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_10584
relatedICD
http://example.org/icd10/H35.5
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_4733
owl#annotatedSource
t365999

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.